How to Get Provigil (Modafinil) in Tennessee

Tennessee Telehealth Prescribing Rules for Modafinil

Tennessee permits telehealth prescribing of Schedule IV controlled substances, including modafinil, once a legitimate provider-patient relationship is established. Under Tennessee Code Annotated § 63-1-155, a provider may establish this relationship through a real-time audio-video encounter without requiring a prior in-person visit. The DEA's post-pandemic telemedicine flexibilities, codified in the final telemedicine prescribing rule effective late 2025, allow an initial 30-day Schedule III-V prescription via telehealth, renewable after follow-up.

This means a Tennessee resident can schedule a video visit with a licensed prescriber, receive a modafinil prescription electronically, and have it filled at a local or mail-order pharmacy the same day. The prescriber must hold an active Tennessee medical license (or multistate compact license recognized in Tennessee) and a valid DEA registration.

Several national telehealth platforms now serve Tennessee patients for wakefulness-promoting agents. Before booking, confirm the platform prescribes Schedule IV medications in your state, as some exclude controlled substances from their formulary. The prescriber will need documentation of your sleep complaint, and most will request prior sleep study results or a referral letter from your primary care provider.

Tennessee's Board of Medical Examiners has not imposed additional telehealth restrictions beyond the statutory requirements. Prescriptions must be transmitted electronically to the pharmacy per Tennessee's electronic prescribing mandate for controlled substances, which took effect in 2021.

Who Can Prescribe Modafinil in Tennessee

Any prescriber with a valid Tennessee license and DEA registration can write a modafinil prescription. That includes physicians (MD and DO), nurse practitioners, and physician assistants. Tennessee granted NPs full practice authority in 2023, meaning NPs no longer require a collaborative agreement with a physician to prescribe Schedule IV drugs independently.

Physician assistants in Tennessee still practice under a supervisory agreement with a physician but retain Schedule II-V prescriptive authority within that agreement. In practice, the prescriber type does not affect your ability to fill the prescription at a Tennessee pharmacy.

Sleep medicine specialists, neurologists, and psychiatrists prescribe modafinil most frequently, but the drug's FDA-approved labeling does not restrict prescribing to any specialty. Primary care providers routinely prescribe it for patients with confirmed narcolepsy or shift-work disorder. The US Modafinil in Narcolepsy Multicenter Study Group demonstrated that modafinil 200-400 mg significantly reduced excessive daytime sleepiness on the Epworth Sleepiness Scale compared to placebo (p<0.001) in a randomized trial of 283 patients with narcolepsy [1].

For off-label cognitive enhancement, prescribers exercise more caution. A 2015 systematic review published in European Neuropsychopharmacology analyzed 24 studies and concluded that modafinil enhances attention, executive function, and learning in non-sleep-deprived individuals, with a favorable side-effect profile [2]. Tennessee does not prohibit off-label prescribing, but insurers will not cover it.

Labs and Documentation Before Starting Modafinil

Most prescribers in Tennessee request a focused workup before writing a modafinil prescription. The specific requirements depend on the indication and the patient's medical history.

For narcolepsy, the gold standard is a polysomnogram (PSG) followed by a Multiple Sleep Latency Test (MSLT). The American Academy of Sleep Medicine (AASM) practice parameters recommend documenting a mean sleep latency of ≤8 minutes with ≥2 sleep-onset REM periods on MSLT to confirm narcolepsy type 1 or type 2. Many Tennessee sleep centers perform both tests in a single overnight-plus-daytime session.

For shift-work disorder, no sleep study is required by the FDA label. A clinical history documenting excessive sleepiness associated with a work schedule that overlaps the habitual sleep period is sufficient. Prescribers typically document the shift schedule and symptom duration.

Baseline labs are not mandated by the FDA label but are commonly ordered. A reasonable pre-prescribing panel includes:

• Complete metabolic panel (CMP) to assess hepatic function, since modafinil is metabolized by CYP3A4 in the liver
• Thyroid-stimulating hormone (TSH) to rule out hypothyroidism as a cause of excessive sleepiness
• Complete blood count (CBC) as a general screening measure
• Urine drug screen at prescriber discretion, particularly for new patients

Cardiac screening deserves attention. Modafinil carries an FDA precaution for patients with left ventricular hypertrophy or mitral valve prolapse. Prescribers may request a baseline EKG in patients with cardiac history or risk factors. A 2019 pharmacovigilance analysis of the FDA Adverse Event Reporting System found that serious cardiovascular events with modafinil were rare, occurring at a rate consistent with background population risk [3].

Insurance Coverage and Prior Authorization in Tennessee

Commercial insurance plans in Tennessee generally cover generic modafinil for FDA-approved indications, but almost all require prior authorization. The PA process creates a documentation bottleneck that delays many prescriptions by 3-7 business days.

TennCare, the state's Medicaid program, does not cover modafinil for narcolepsy, shift-work disorder, or off-label uses. This is an exception to many other state Medicaid programs. TennCare's preferred drug list restricts wakefulness-promoting agents, leaving patients on TennCare to explore manufacturer assistance programs or cash-pay options.

For commercial plans, the prior authorization typically requires:

• Confirmed diagnosis with ICD-10 code (G47.419 for narcolepsy without cataplexy, G47.26 for shift-work disorder)
• Sleep study results for narcolepsy claims
• Documentation of shift schedule for shift-work disorder claims
• Trial and failure of non-pharmacologic interventions (some plans)
• Prescriber attestation that the patient does not have a contraindicated cardiac condition

BlueCross BlueShield of Tennessee, the state's largest commercial insurer, requires a PA for both brand Provigil and generic modafinil. Their step-therapy protocol may require documentation that the patient has tried or cannot tolerate other wakefulness agents. Cigna and UnitedHealthcare plans sold on the Tennessee exchange follow similar PA pathways.

Peer-to-peer review is available if the initial PA is denied. The prescriber calls the plan's medical director to present the clinical case. According to a 2021 JAMA Internal Medicine study, peer-to-peer reviews overturn initial PA denials approximately 75% of the time for established medications [4].

A practical tip: submit the PA before the patient visit ends. Many EHR systems integrate electronic prior authorization (ePA), which can return a decision in under an hour for straightforward narcolepsy cases.

Cash-Pay and Pharmacy Options Across Tennessee

When insurance is unavailable or the PA is denied, generic modafinil remains affordable as a cash-pay medication. The average retail price for 30 tablets of modafinil 200 mg in Tennessee ranges from $30 to $80 depending on the pharmacy. Brand Provigil, manufactured originally by Cephalon (now Teva), costs significantly more and is rarely stocked.

National chains like CVS, Walgreens, and Walmart all dispense modafinil at Tennessee locations. Independent pharmacies may offer lower cash prices, particularly in Nashville, Memphis, Knoxville, and Chattanooga metro areas. GoodRx and RxSaver coupons can reduce the price to under $35 at many locations.

Tennessee's 503A compounding pharmacies are licensed by the Tennessee Board of Pharmacy and can compound modafinil into custom formulations (such as lower-dose capsules or sublingual preparations) when a prescriber writes a patient-specific prescription. This option suits patients who need non-standard doses or cannot swallow tablets. Compounded modafinil is not subject to the same insurance formulary restrictions, but it is always a cash-pay item. Expect compounded preparations to cost $50-$120 for a 30-day supply depending on the formulation.

Mail-order pharmacies represent another access pathway. Express Scripts, OptumRx, and CVS Caremark all ship Schedule IV medications to Tennessee addresses. A 90-day mail-order fill often costs less per tablet than a 30-day retail fill, even at cash-pay rates. Verify that the mail-order pharmacy holds a Tennessee non-resident pharmacy license, which the Tennessee Board of Pharmacy requires for any out-of-state pharmacy shipping controlled substances into the state.

Transferring a Modafinil Prescription to Tennessee

Patients relocating to Tennessee or traveling within the state can transfer an existing modafinil prescription from another state under certain conditions. Tennessee follows the DEA's federal transfer rules for Schedule III-V medications: one transfer is permitted between pharmacies for the remaining refills on a valid prescription [5].

The process works like this. Call the Tennessee pharmacy where you want to fill the prescription. Provide them with the originating pharmacy's name, phone number, and your prescription number. The receiving pharmacist contacts the transferring pharmacy to verify the prescription details, remaining refills, and DEA number. The transfer typically completes within 30 minutes to 2 hours.

Electronic prescriptions complicate transfers slightly. Some pharmacy software systems handle e-prescription transfers internally (within the same chain) but cannot transfer them across chains. If the transfer fails electronically, ask your prescriber to send a new electronic prescription to the Tennessee pharmacy. This is often the faster path.

Tennessee law requires that the prescriber's license be verifiable, but does not require the prescriber to hold a Tennessee license for a transferred prescription. The prescription must have been legally issued in the originating state. Patients with prescriptions from states that have stricter telehealth rules (like certain pre-2025 regulations in Louisiana or Alabama) should confirm the prescription was issued in compliance with the originating state's laws.

Modafinil Dosing, Safety, and Monitoring

The FDA-approved dose of modafinil is 200 mg taken once daily in the morning for narcolepsy and obstructive sleep apnea, and approximately one hour before the start of a work shift for shift-work disorder [6]. The maximum recommended dose is 400 mg per day, though the US Modafinil in Narcolepsy Study Group found no statistically significant additional benefit at 400 mg compared to 200 mg in their key trial of 283 patients (Ann Neurol 1998) [1].

Common side effects include headache (34% in clinical trials vs. 23% placebo), nausea (11%), and nervousness (7%). Serious dermatologic reactions, including Stevens-Johnson syndrome, have been reported rarely. The FDA label recommends discontinuing modafinil at the first sign of rash [6].

Drug interactions require attention. Modafinil induces CYP3A4 and inhibits CYP2C19. It reduces the efficacy of hormonal contraceptives, a fact that prescribers in Tennessee must communicate clearly. The FDA label recommends alternative or additional contraception during treatment and for one month after discontinuation. Modafinil may also increase levels of drugs metabolized by CYP2C19, including omeprazole, phenytoin, and diazepam.

"Modafinil has a relatively low abuse potential compared to traditional psychostimulants, which is reflected in its Schedule IV classification," noted Dr. Charles Czeisler, professor of sleep medicine at Harvard Medical School, in a review of wakefulness-promoting agents published in the New England Journal of Medicine [7].

Follow-up monitoring is straightforward. Most prescribers schedule a check-in at 4-6 weeks after initiation, then every 3-6 months. Monitoring focuses on symptom response (using the Epworth Sleepiness Scale), blood pressure, heart rate, and any emerging side effects. Annual hepatic function testing is reasonable for patients on long-term therapy, though not required by the label.

"For patients with narcolepsy, the goal is functional improvement, not just reducing sleepiness scores. We ask about driving safety, work performance, and quality of life at every visit," stated the AASM practice guideline committee in their 2021 update on the treatment of central disorders of hypersomnolence [8].

Timeline from First Visit to Filled Prescription

The total time from initial appointment to having modafinil in hand varies depending on the pathway chosen.

Fastest pathway (cash pay, no insurance): A patient books a telehealth visit, receives the prescription electronically during the appointment, and fills it at a local pharmacy the same day. Total time: 1-3 hours from appointment start to medication pickup.

Standard pathway (commercial insurance with PA): The prescriber submits a prior authorization during or after the visit. ePA decisions arrive in 1-24 hours for automated approvals. Manual reviews take 3-7 business days. After approval, the pharmacy fills the prescription the same day. Total time: 1-8 days.

Complex pathway (PA denial with appeal): If the initial PA is denied, the prescriber files a peer-to-peer review or formal appeal. This adds 5-15 business days. Some patients fill a short cash-pay supply while awaiting the appeal decision.

Mail-order pathway: After prescription and PA approval, mail-order pharmacies ship within 3-5 business days. Some offer overnight shipping for an additional fee. Total time from prescription to delivery: 4-7 days.

Tennessee pharmacies do not impose additional state-level waiting periods for Schedule IV prescriptions beyond the standard federal dispensing rules. A pharmacist can fill a modafinil prescription immediately upon receipt if it passes verification checks.